**Core Concept**
Ciprofloxacin, a fluoroquinolone antibiotic, can interact with theophylline, a methylxanthine used in asthma, through a complex mechanism involving enzyme inhibition and induction, leading to increased theophylline levels and potential toxicity.

**Why the Correct Answer is Right**
Ciprofloxacin inhibits the cytochrome P450 1A2 (CYP1A2) enzyme, which is responsible for theophylline metabolism. This inhibition leads to reduced theophylline clearance, causing increased theophylline plasma concentrations. As a result, theophylline toxicity, including symptoms such as nausea, vomiting, and seizures, may occur. The interaction is particularly concerning in asthmatic patients, as theophylline is a narrow therapeutic index medication.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not address the specific mechanism of the interaction between ciprofloxacin and theophylline.

**Option B:** This option is incorrect because it implies that ciprofloxacin is contraindicated in asthmatic patients, which is not the case. Ciprofloxacin can be used in asthma patients, but with caution and monitoring of theophylline levels.

**Option C:** This option is incorrect because it does not provide a clear explanation for the interaction between ciprofloxacin and theophylline.

**Clinical Pearl / High-Yield Fact**
Remember the "CYP" acronym to associate with enzyme inhibition and induction. In this case, Ciprofloxacin inhibits CYP1A2, causing increased theophylline levels and potential toxicity.

**Correct Answer:** C.